Hypermedica Spółka z Ograniczoną Odpowiedzialnością (KRS 0000280585, NIP 8272288597) is a Polish company, headquartered in Gdynia, Pomorskie voivodeship. Hypermedica operates in: Paramedical activities (PKD 86.90.D). Industry: Healthcare. The company has been listed in the National Court Register since May 15, 2007. Hypermedica's most recently reported net revenue was 0 PLN for 2023.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Hypermedica
Identity
- Name
- Hypermedica Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 15, 2007
- Registry status as of
- December 31, 2025
- Latest entry
- December 30, 2025
- Founding act
- 21.07.2022 R., REPERTORIUM A NR 11937/2022, NOTARIUSZ ANNA TARASIUK PROWADZĄCA KANCELARIĘ NOTARIALNĄ ANNA TARASIUK, UL. …
Articles of association history (2)
- AKT NOTARIALNY Z 30 MARCA 2007 R. SPORZĄDZONY PRZEZ NOTARIUSZ KATARZYNĘ SOBAŃSKĄ TIUTIUNIK W KANCELARII NOTARIALNEJ W ŁODZI, REPERTORIUM A NR 201/2007.
- July 21, 2022: 21.07.2022 R., REPERTORIUM A NR 11937/2022, NOTARIUSZ ANNA TARASIUK PROWADZĄCA KANCELARIĘ NOTARIALNĄ ANNA TARASIUK, UL. ARMII KRAJOWEJ 28/8, 81-366 GDYNIA, UCHYLENIE DOTYCHCZASOWEJ TREŚCI UMOWY SPÓŁKI I PRZYJĘCIE NOWEJ TREŚCI UMOWY SPÓŁKI.
Activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. WŁADYSŁAWA IV, 43, 80-395, GDYNIA, POLSKA
- Voivodeship
- POMORSKIE
- District
- GDYNIA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 54.5064, 18.4795approx.
Risk and payment profile - Hypermedica
Credibility rating
54 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
5
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/19 yrs
Board changes
1
1/19 yrs
PKD changes
2
2/19 yrs
Name changes
1
1/19 yrs
Data from 19 years of registry activity.
Credibility history
Payment reliability score from 2021–2023
Current: D (54/100)
Trend: stable (0.0 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2021–2023
Current: 9.7 K PLN
Safe: 2.9 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Hypermedica
Founded
May 15, 2007
19 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GDYNIA
POMORSKIE
Primary PKD
86.90.D
Paramedical activities
Share capital
60.0 K PLN
120 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
2 years
2021–2023
Registry entries
36
latest: December 30, 2025
Revenue
0 PLN
2023
Net profit
0 PLN
2023
Assets
60.0 K PLN
2023
Equity
60.0 K PLN
2023
EBITDA
N/A
2023
no depreciation data
Valuation
51.0 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Hypermedica.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the world's first and Poland's first accredited longevity-medicine educational programme for doctors. Accreditation comes from the Polish Medical Chamber; the scientific partner is the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of a medical-imaging centre network (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. Founded in 2005 and listed on the WSE since 2011, it operates under the Voxel-Diagnostic brand at several dozen locations across Poland. According to its 2025 financial statements, revenue reached PLN 583.8 million (up 15% year on year) with net profit of PLN 98.5 million. A two-member management board, a five-member supervisory board.
